Astellas Pharma Inc. total revenue, net income and dynamics of changes in Euro today
Net revenue of Astellas Pharma Inc. on 30/06/2021 amounted to 326 143 000 000 €. Net income Astellas Pharma Inc. - 30 687 000 000 €. Information about net income is used from open sources. Here are the main financial indicators of Astellas Pharma Inc.. The financial report on the chart of Astellas Pharma Inc. allows you to clearly see the dynamics of fixed assets. Astellas Pharma Inc. net income is shown in blue on the graph. All information on Astellas Pharma Inc. total revenue on this chart is created in the form of yellow bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
30/06/2021
304 611 691 426 €
-2.392 % ↓
28 661 105 634 €
-47.56 % ↓
31/03/2021
288 246 458 822 €
+2.42 % ↑
-11 514 130 096 €
-140.1171 % ↓
31/12/2020
303 942 960 314 €
-3.738 % ↓
56 112 704 578 €
-2.301 % ↓
30/09/2020
288 144 654 784 €
-2.473 % ↓
20 944 546 350 €
-67.968 % ↓
31/12/2019
315 746 624 830 €
-
57 434 289 108 €
-
30/09/2019
295 452 129 952 €
-
65 387 145 838 €
-
30/06/2019
312 075 141 588 €
-
54 654 758 676 €
-
31/03/2019
281 427 456 240 €
-
28 701 266 860 €
-
Show:
to
Astellas Pharma Inc. financial report charts
The dates of the latest financial statements of Astellas Pharma Inc.: 31/03/2019, 31/03/2021, 30/06/2021. The dates of the financial statements are determined by the accounting rules. The latest date of the financial report of Astellas Pharma Inc. is 30/06/2021. Gross profit Astellas Pharma Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Astellas Pharma Inc. is 263 912 000 000 €
Astellas Pharma Inc. quarterly report dates
Cost of revenue Astellas Pharma Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Astellas Pharma Inc. is 62 231 000 000 € Total revenue Astellas Pharma Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Astellas Pharma Inc. is 326 143 000 000 € Operating income Astellas Pharma Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Astellas Pharma Inc. is 35 797 000 000 €
Net income Astellas Pharma Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Astellas Pharma Inc. is 30 687 000 000 € Current assets Astellas Pharma Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Astellas Pharma Inc. is 868 715 000 000 € Total assets Astellas Pharma Inc. refers to the total amount of assets owned by a person or entity. Total assets Astellas Pharma Inc. is 2 249 456 000 000 €
30/06/2021
31/03/2021
31/12/2020
30/09/2020
31/12/2019
30/09/2019
30/06/2019
31/03/2019
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
246 489 057 584 €
233 770 090 708 €
240 257 529 680 €
232 202 868 912 €
238 441 868 672 €
231 605 120 432 €
246 218 202 804 €
221 335 988 342 €
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
58 122 633 842 €
54 476 368 114 €
63 685 430 634 €
55 941 785 872 €
77 304 756 158 €
63 847 009 520 €
65 856 938 784 €
60 091 467 898 €
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
304 611 691 426 €
288 246 458 822 €
303 942 960 314 €
288 144 654 784 €
315 746 624 830 €
295 452 129 952 €
312 075 141 588 €
281 427 456 240 €
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
-
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
33 433 753 654 €
85 176 356 454 €
67 802 423 290 €
24 564 660 582 €
71 203 051 752 €
80 124 447 816 €
72 677 809 330 €
67 193 467 026 €
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
28 661 105 634 €
-11 514 130 096 €
56 112 704 578 €
20 944 546 350 €
57 434 289 108 €
65 387 145 838 €
54 654 758 676 €
28 701 266 860 €
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
54 463 292 366 €
51 992 909 976 €
53 349 051 840 €
50 819 828 584 €
51 163 533 960 €
48 069 251 594 €
49 974 574 874 €
54 846 224 986 €
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
271 177 937 772 €
203 070 102 368 €
236 140 537 024 €
263 579 994 202 €
244 543 573 078 €
215 327 682 136 €
239 397 332 258 €
214 233 989 214 €
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
811 364 173 130 €
814 981 485 416 €
806 301 056 708 €
765 773 709 764 €
779 081 085 300 €
799 111 263 272 €
765 986 657 660 €
800 571 077 138 €
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
2 100 951 413 792 €
2 123 527 626 696 €
2 145 210 018 826 €
2 089 332 677 712 €
1 858 417 769 978 €
1 849 112 507 312 €
1 799 812 267 442 €
1 772 369 074 336 €
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
281 987 845 440 €
304 597 681 696 €
286 278 558 748 €
267 804 394 788 €
259 275 271 164 €
290 811 173 394 €
242 295 478 404 €
290 537 516 668 €
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
435 289 782 956 €
451 697 978 732 €
433 518 953 084 €
463 029 982 338 €
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
627 946 920 006 €
638 545 747 742 €
632 607 490 186 €
597 049 861 464 €
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
33.79 %
34.53 %
35.15 %
33.69 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
1 291 574 754 358 €
1 294 606 459 930 €
1 278 256 171 038 €
1 241 848 618 696 €
1 230 470 849 972 €
1 210 566 759 570 €
1 167 204 777 256 €
1 175 319 212 872 €
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
64 100 118 642 €
88 025 001 554 €
6 922 674 584 €
51 321 376 918 €
Last revenue report of Astellas Pharma Inc. was 30/06/2021. According to last financial report total revenue in Astellas Pharma Inc. was 304 611 691 426 Euro and changed by -2.392% since last year. Net income in Astellas Pharma Inc. was 28 661 105 634 € in last quartal, net income changes to -47.56%.
Current cash Astellas Pharma Inc. - the sum of all of the cash a company has on the date of report. Current cash Astellas Pharma Inc. is 301 920 000 000 €
Astellas Pharma Inc. stocks data
YPH.F stock price
Astellas Pharma Inc. stock price today, YPH.F stock quote.
